Polyphenol-based nanoplatform for MRI/PET dual-modality imaging guided effective combination chemotherapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Combination chemotherapy is standard for cancer treatment.
• Polyphenol-based materials offer biocompatibility and disease prevention.
• Developing effective drug delivery systems is crucial for cancer therapy.

Purpose of the Study:

• To create a polyphenol-based nanoplatform for co-delivering two chemotherapeutic drugs.
• To evaluate the efficacy and tumor targeting of these nanoparticles in vitro and in vivo.
• To explore the potential of this nanoplatform as a theranostic agent.

Main Methods:

• Synthesis of amphiphilic poly(ethylene glycol)-block-polydopamine (PEG-PDA) via RAFT polymerization.
• Preparation of nanoparticles through self-assembly using Fe³⁺ or Mn²⁺ cross-linkers.
• Encapsulation of doxorubicin (DOX) and simvastatin (SV) within the nanoparticles.
• In vitro evaluation of cell viability and combination index.
• In vivo tumor accumulation assessment using PET and MR imaging.

Main Results:

• Nanoparticles exhibited high drug loading capacity.
• Drug-loaded nanoparticles effectively killed cancer cells (combination index <1).
• PET and MRI confirmed long blood circulation and significant tumor accumulation.
• Intravenous injection of nanoparticles inhibited tumor growth.

Conclusions:

• The developed polyphenol-based nanoplatform successfully co-delivers chemotherapeutic drugs.
• The nanoparticles demonstrate potent anti-cancer activity and effective tumor targeting.
• This nanoplatform shows significant potential as a theranostic agent for clinical cancer therapy.